Similar Search Results

Exploring a regional pharmaceutical innovation network as a possible solution to the market failure in the innovation of essential medicines for tropical diseases in sub-Saharan Af...

Manu, Thaddeus - In: African journal of science, technology, innovation & … 6 (2014) 1/2, pp. 111-125

Persistent link: https://www.econbiz.de/10011337301

The effect of intellectual property rights on domestic innovation in the pharmaceutical sector

Gamba, Simona - 2016

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …

Persistent link: https://www.econbiz.de/10011509446

Pharmaceutical innovation, longevity, and medical expenditure in Greece, 1995 - 2010

Lichtenberg, Frank - 2015

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

Persistent link: https://www.econbiz.de/10010473542

The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997 - 2010 : evidence from longitudinal, disease-level data

Lichtenberg, Frank R.; Pettersson, Billie - In: Economics of innovation and new technology 23 (2014) 3/4, pp. 239-273

Persistent link: https://www.econbiz.de/10010407486

Mapping Markush

Wagner, Stefan; Sternitzke, Christian; Walter, Sascha G. - 2022

the functioning of the patent system, innovation researchers have been surprisingly silent on the topic. This paper …

Persistent link: https://www.econbiz.de/10013278879

The impact of pharmaceutical innovation on cancer mortality in Belgium : 2004-2012

Lichtenberg, Frank R. - In: Forum for health economics & policy : an evolving … 20 (2017) 1, pp. 1-28

Persistent link: https://www.econbiz.de/10011701670

The effect of intellectual property rights on domestic innovation in the pharmaceutical sector

Gamba, Simona - In: World development : the multi-disciplinary … 99 (2017), pp. 15-27

Persistent link: https://www.econbiz.de/10011925529

Have pharmaceutical R&D project success rates decreased? : a critical review and new empirical results

Backfisch, Martin - 2017 - Version: 30 October 2017

In the context of the ongoing debate about an innovation crisis in the pharmaceutical industry, we study the success …

Persistent link: https://www.econbiz.de/10011773501

Imitation and innovation new biologics, biosimilars and biobetters

Niosi, Jorge E. - In: Technology analysis & strategic management 29 (2017) 3, pp. 251-262

Persistent link: https://www.econbiz.de/10011710347

Pharmaceutical spending and early-stage innovation in EU countries

Kourouklis, Dimitrios; Gandjour, Afschin - In: Industry and innovation 29 (2022) 10, pp. 1141-1170

Persistent link: https://www.econbiz.de/10013493053